Aridia names CFO
This article was originally published in Scrip
San Jose, California-based Aridis Pharmaceuticals, a biopharmaceutical company developing novel anti-infectives and immunotherapies for infectious diseases, has appointed Fred Kurland, chief financial officer. Prior to joining Aridis, Mr Kurland was CFO, vice-president of finance and secretary of XOMA since December 2008.
You may also be interested in...
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.
A selection of features you might have missed from the first six months of 2020, covering key topics from COVID-19 strategies in medtech to an analysis of pipeline focus areas across the pharma sector. Click on each section to get the full story behind the data.
The two-part vaccine becomes the second against Ebola to get approval. Janssen is now collaborating with the World Health Organization on vaccine pre-qualification to get it to people in need.